Forte Biosciences ($FBRX) Insider Trading & Smart Money Activity

Forte Biosciences, Inc. · Biotechnology · Latest filing Jun 16, 2026

Forte Biosciences, Inc. ($FBRX) has 4 insider trades on file. Insiders filed 4 Form 4 transactions in the last 12 months, none of them open-market purchases or sales.

Insider buyers (12 mo): 0
Insider sellers (12 mo): 0
Net insider $ (12 mo): $0
Congress trades (12 mo): 0
13F moves on file: 0
Analyst ratings on file: 0

FBRX insider buying and selling by quarter

Quarter	Congress buys / sales	13F added / cut
Q1 2026	0 / 0	0 / 0
Q2 2026	0 / 0	0 / 0
Q3 2026	0 / 0	0 / 0
Q4 2026	0 / 0	0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All FBRX insider, congress, 13F and analyst activity

Date	Source	Who	Action	Shares	Story
Jun 16, 2026	Insider	Paul WagnerSEE REMARKS	Buy (Grant or award)	500K sh	Read
Jun 16, 2026	Insider	Paul WagnerSEE REMARKS	Buy (Grant or award)	500K sh	—
Jun 16, 2026	Insider	Antony RileyCHIEF FINANCIAL OFFICER	Buy (Grant or award)	22K sh	—
Jun 16, 2026	Insider	Antony RileyCHIEF FINANCIAL OFFICER	Buy (Grant or award)	22K sh	—

1W / 1M / 6M = how FBRX moved from the trade or filing date.

Insider trading in FBRX: who is buying and selling

Insider	Role	Trades	Open-market net	Shares held	Last trade
Paul Wagner	SEE REMARKS	2	—		Jun 16, 2026
Antony Riley	CHIEF FINANCIAL OFFICER	2	—		Jun 16, 2026

Frequently asked questions

What is the latest insider trade in FBRX?

Paul Wagner, SEE REMARKS filed a buy (grant or award) of 500K sh on Jun 16, 2026.

Other biotechnology stocks

All stocks Insider cluster buys Top insider purchases Congress 13F institutions

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text